Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

(2021) Noa Dagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study

(2021) Maria E. Sundaram et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel

(2021) Melanie D Swift et al.   CLINICAL INFECTIOUS DISEASES

Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers

(2021) Yoel Angel et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce

(2021) Li Tang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

(2021) Eleftheria Vasileiou et al.   LANCET

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

(2021) Eric J Haas et al.   LANCET

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

(2021) Victoria Jane Hall et al.   LANCET

Beyond the First Dose — Covid-19 Vaccine Follow-through and Continued Protective Measures

(2021) Jillian L. Goldfarb et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

(2021) Jamie Lopez Bernal et al.   BMJ-British Medical Journal

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

(2021) Mark W. Tenforde et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

(2021) Mark G. Thompson et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting

(2021) Adeel A. Butt et al.   ANNALS OF INTERNAL MEDICINE

Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study

(2021) Catherine Hyams et al.   LANCET INFECTIOUS DISEASES

mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

(2021) Hiam Chemaitelly et al.   NATURE MEDICINE

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

(2021) Mark G. Thompson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Postlicensure Evaluation of COVID-19 Vaccines

(2020) Manish M. Patel et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort

(2019) Jeffrey C. Kwong et al.   VACCINE

Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness

(2016) Sheena G. Sullivan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The test-negative design for estimating influenza vaccine effectiveness

(2013) Michael L. Jackson et al.   VACCINE